The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity
- PMID: 6971309
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity
Abstract
The participation of herpes simplex virus (HSV) glycoproteins in T cell-mediated lysis of HSV-infected syngeneic target cells was examined by using a temperature sensitive (ts) mutant defective in glycoprotein synthesis at the nonpermissive temperature (39 degrees C), and 2-deoxy-D-glucose and tunicamycin, known inhibitors of both HSV replication and glycoprotein synthesis in HSV-infected cells. Lymphocytes cytotoxic for HSV-infected cells lysed C57BL/6 Wt-3 cells infected with the mutant, ts A1, at 39 degrees C less efficiently than at 33 degrees C. Treatment of HSV-infected C57BL/6 Wt-3 cells with 1% 2-deoxy-D-glucose for 14 hr reduced their susceptibility to T cell-mediated lysis by 73% in the 51Cr release assay. Treatment of HSV-infected C57BL/6 Wt-3 cells with 0.2 microgram/ml tunicamycin for 14 hr reduced their susceptibility to T cell-mediated lysis by 78% in the 51Cr release assay. The reduction in T cell-mediated lysis by 2 deoxy-D-glucose and tunicamycin was found not to be due to the effects of the compounds on the H-2 antigens. We conclude that HSV specific glycoproteins are involved in T cell-mediated lysis of HSV-infected cells.
Similar articles
-
Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.J Immunol. 1984 Jan;132(1):475-81. J Immunol. 1984. PMID: 6197457
-
Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.J Immunol. 1986 May 1;136(9):3473-80. J Immunol. 1986. PMID: 2420891
-
Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.J Immunol. 1990 Jun 15;144(12):4536-40. J Immunol. 1990. PMID: 2161874
-
Cell-mediated immunity and immunosuppression in herpes simplex virus infection.Immunodeficiency. 1993;5(1):33-90. Immunodeficiency. 1993. PMID: 8167747 Review.
-
Resistance to herpes simplex virus - type 1 (HSV-1).Curr Top Microbiol Immunol. 1981;92:15-24. doi: 10.1007/978-3-642-68069-4_2. Curr Top Microbiol Immunol. 1981. PMID: 6171384 Review. No abstract available.
Cited by
-
Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.J Virol. 1984 Sep;51(3):656-61. doi: 10.1128/JVI.51.3.656-661.1984. J Virol. 1984. PMID: 6088790 Free PMC article.
-
Expression of cell-associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells.J Virol. 1987 Feb;61(2):315-25. doi: 10.1128/JVI.61.2.315-325.1987. J Virol. 1987. PMID: 3027363 Free PMC article.
-
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.Proc Natl Acad Sci U S A. 1987 Aug;84(16):5908-12. doi: 10.1073/pnas.84.16.5908. Proc Natl Acad Sci U S A. 1987. PMID: 3303033 Free PMC article.
-
Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice.Immunology. 1984 Jan;51(1):57-64. Immunology. 1984. PMID: 6317545 Free PMC article.
-
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.J Virol. 1986 Jul;59(1):142-53. doi: 10.1128/JVI.59.1.142-153.1986. J Virol. 1986. PMID: 2423702 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical